Trial Profile
A Multi-Center, Randomized, Double-Masked Evaluation of Anti-Inflammatory Treatment in Patients With Dry Eye
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2014
Price :
$35
*
At a glance
- Drugs Difluprednate (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Alcon
- 23 Dec 2014 New trial record